Revenue
2018
2019
2020
2021
2022
2023
2024
2025
MERIT MEDICAL SYSTEMS INC (MMSI)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.52B | $1.36B | $1.26B | $1.15B | $1.07B | $963.9M | $994.9M | $882.8M | $727.9M | $603.8M | — | — | — | — | $359.4M | $296.8M | $257.5M |
| Gross profit | $738.3M | $643.3M | $583.9M | $519.1M | $485.3M | $401.2M | $432.4M | $394.8M | $326.3M | $265.0M | $235.8M | $225.2M | $194.4M | $182.0M | $165.5M | $128.5M | $108.8M |
| Research & development | $97.4M | $87.5M | $82.7M | $75.5M | $71.2M | $57.5M | $65.6M | $59.5M | $51.4M | $45.2M | $40.8M | $36.6M | $33.9M | $27.8M | $21.9M | $15.3M | $11.2M |
| Operating expenses | $553.5M | $487.6M | $459.9M | $431.5M | $424.4M | $402.7M | $416.9M | $336.2M | $293.2M | $230.1M | $198.2M | $185.1M | $166.5M | $152.4M | $132.3M | $111.3M | $76.0M |
| Operating income | $184.7M | $155.7M | $123.9M | $87.6M | $60.9M | −$1.6M | $15.4M | $58.6M | $33.1M | $34.9M | $37.5M | $40.2M | $27.8M | $29.6M | $33.2M | $17.2M | $32.8M |
| EBITDAderived | $307.9M | $258.4M | $213.9M | $169.4M | $145.0M | $92.5M | $107.5M | $128.2M | $86.7M | $78.6M | $75.0M | $76.1M | $60.4M | $52.2M | $52.4M | $32.1M | $45.1M |
| Net income | $128.5M | $120.4M | $94.4M | $74.5M | $48.5M | −$9.8M | $5.5M | $42.0M | $27.5M | $20.1M | $23.8M | $23.0M | $16.6M | $19.7M | $23.0M | $12.5M | $22.5M |
| Basic EPSper diluted share | $2.17 | $2.07 | $1.64 | $1.31 | $0.86 | -$0.18 | $0.10 | $0.80 | $0.56 | $0.45 | $0.54 | $0.53 | $0.39 | $0.47 | $0.59 | $0.35 | $0.64 |
| Diluted EPSper diluted share | $2.13 | $2.03 | $1.62 | $1.29 | $0.84 | -$0.18 | $0.10 | $0.78 | $0.55 | $0.45 | $0.53 | $0.53 | $0.39 | $0.46 | $0.58 | $0.35 | $0.63 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 11, 2026Form 4 | Smith Christian AdamChief Commercial Officer | BuyCommon Stock, No Par Value · indirect | 1.6K | $61.00 | $99.2K | 2.2K |
| May 7, 2026Form 4 | Ward Lynne N.Director | SellCommon Stock, No Par Value | 5.0K | $62.61 | $313.1K | 7.8K |
| May 7, 2026Form 4 | Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY | BuyCommon Stock, No Par Value · indirect | 2.0K | $62.63 | $125.3K | 2.0K |
| May 6, 2026Form 4 | Parra Raul Jr.CFO AND TREASURER | BuyCommon Stock, No Par Value | 1.5K | $61.01 | $91.5K | 58.8K |
| May 6, 2026Form 4 | Aronson Martha GoldbergPresident and CEO | BuyCommon Stock, No Par Value | 2.0K | $60.44 | $120.9K | 49.8K |